SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-228165
Filing Date
2010-10-12
Accepted
2010-10-12 17:02:45
Documents
3
Period of Report
2010-10-08
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 31078
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF ZYMOGENETICS, INC. dex31.htm EX-3.1 17484
3 BYLAWS OF ZYMOGENETICS, INC. dex32.htm EX-3.2 76541
  Complete submission text file 0001193125-10-228165.txt   127121
Mailing Address 1201 EASTLAKE AVENUE E SEATTLE WA 98102
Business Address 1201 EASTLAKE AVENUE E SEATTLE WA 98102 206-442-6600
ZYMOGENETICS INC (Filer) CIK: 0001129425 (see all company filings)

IRS No.: 911144498 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33489 | Film No.: 101119799
SIC: 2836 Biological Products, (No Diagnostic Substances)